文献速递乳腺US

乳腺癌新辅助化疗中预测病理完全缓解:剪切波弹性成像在临床常规中是否有用?

Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?
PubMed 文献 · Eur J Radiol · 2020-05-01

这项前瞻性连续临床试验在常规临床实践中纳入134例接受新辅助化疗的乳腺癌患者,以手术标本病理为参考标准,比较剪切波弹性成像(SWE)与标准临床评估对病理完全缓解(pCR,ypT0)的预测效能。SWE测量的剪切波速度在pCR组各随访点均显著低于非pCR组,ROC分析显示中等AUC;以≤3.35 m/s为阈值,SWE敏感度(79.6% vs 54.5%)和阴性预测值(86.4% vs 77.5%)优于标准临床评估,但特异度(58.6% vs 77.5%)较低。

要点

  • SWE以≤3.35 m/s为阈值预测pCR的敏感度为79.6%、阴性预测值为86.4%,均优于标准临床评估。
  • SWE特异度仅58.6%,低于标准临床评估的77.5%,假阳性率41.4%。
  • pCR组剪切波速度在新辅助化疗各随访点均显著低于非pCR组(p<0.001)。

诊断标准与关键数值

  • 剪切波速度(Vs)预测pCR的ROC分析AUC:总人群t0为0.613、t1为0.745、t2为0.685、tEND为0.718。
  • Vs(tEND)以≤3.35 m/s为阈值预测pCR:敏感度79.6%、特异度58.6%、阴性预测值86.4%、阳性预测值46.3%、假阴性率20.4%、假阳性率41.4%。
  • 标准临床评估(体格检查、乳腺X线摄影和B型超声,ycT+ vs ycT0)预测pCR:敏感度54.5%、特异度77.5%、阴性预测值77.5%、阳性预测值54.5%、假阴性率45.5%、假阳性率22.5%。
  • pCR定义:ypT0。

临床应用与阅片要点

  • SWE可作为新辅助化疗期间无创评估肿瘤弹性变化的辅助手段,以Vs(tEND)≤3.35 m/s预测pCR时敏感度和阴性预测值较高。
  • SWE预测pCR的特异度偏低(58.6%),假阳性率41.4%,阅片和报告时需结合标准临床评估综合判断。

局限性

  • 作者指出SWE在常规条件下预测pCR时特异度不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the validity of Shear Wave Elastography (SWE) for the preoperative assessment of pathological complete response (pCR) to standard clinical assessment in breast cancer patients undergoing neoadjuvant chemotherapy (NACT).

MATERIALS AND METHODS: This prospective, consecutive clinical trial was conducted under routine clinical practice. Analysis included 134 patients. SWE served as index test, final pathology from surgical specimen as reference standard. PCR (ypT0) was defined as primary endpoint. Elasticity changes were compared for the pCR- vs. non-pCR group. To determine the validity of shear wave velocity (Vs), ROC analyses and diagnostic accuracy parameters were calculated and compared to the final standard clinical assessment by physical examination, mammography and B-mode ultrasound (ycT + vs. ycT0).

RESULTS: Vs was significantly reduced in pCR and non-pCR groups during NACT (pCR: ΔVs(abs) = 3.90 m/s, p < 0.001; non-pCR: ΔVs(abs) = 3.10 m/s, p < 0.001). The pCR-group showed significant lower Vs for all control visits (t1,2,END: p < 0.001). ROC analysis of Vs yielded moderate AUCs for the total population (t0: 0.613, t1: 0.745, t2: 0.685, tEND: 0.718). Compared to standard clinical assessment, Vs(tEND) (cut-off: ≤3.35 m/s) was superior in sensitivity (79.6 % vs. 54.5 %), NPV (86.4 % vs. 77.5 %), FNR (20.4 % vs. 45.5 %), inferior in specificity (58.6 % vs. 77.5 %), PPV (46.3 % vs. 54.5 %), FPR (41.4 % vs. 22.5 %).

CONCLUSION: SWE measures significant differences in tumour elasticity changes in pCR vs. non-pCR cases. SWE shows improved sensitivity compared to standard clinical assessment, high NPV and low FNR, but failed in specificity in order to predict pCR under routine conditions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Maier AM, Heil J, Harcos A, et al. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine? Eur J Radiol. 2020. PMID: 32371182. doi:10.1016/j.ejrad.2020.109025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。